Cargando…

Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease

BACKGROUND: Previous studies have shown that tuberculosis (TB) is a risk factor for chronic airflow limitation. Chronic obstructive pulmonary disease (COPD) is recognized as the result of chronic inflammation, usually related to noxious particles. Post-TB airflow obstruction and tobacco-related COPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Guiedem, Elise, Pefura-Yone, Eric Walter, Ikomey, George Mondinde, Nkenfou, Céline Nguefeu, Mesembe, Martha, Yivala, Mbanyamsig Mispa, Chendi, Bih Hycenta, Jacobs, Graeme Brendon, Chegou, Novel Njweipi, Okomo, Marie Claire Assoumou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528576/
https://www.ncbi.nlm.nih.gov/pubmed/32998687
http://dx.doi.org/10.1186/s12865-020-00381-w
_version_ 1783589289559326720
author Guiedem, Elise
Pefura-Yone, Eric Walter
Ikomey, George Mondinde
Nkenfou, Céline Nguefeu
Mesembe, Martha
Yivala, Mbanyamsig Mispa
Chendi, Bih Hycenta
Jacobs, Graeme Brendon
Chegou, Novel Njweipi
Okomo, Marie Claire Assoumou
author_facet Guiedem, Elise
Pefura-Yone, Eric Walter
Ikomey, George Mondinde
Nkenfou, Céline Nguefeu
Mesembe, Martha
Yivala, Mbanyamsig Mispa
Chendi, Bih Hycenta
Jacobs, Graeme Brendon
Chegou, Novel Njweipi
Okomo, Marie Claire Assoumou
author_sort Guiedem, Elise
collection PubMed
description BACKGROUND: Previous studies have shown that tuberculosis (TB) is a risk factor for chronic airflow limitation. Chronic obstructive pulmonary disease (COPD) is recognized as the result of chronic inflammation, usually related to noxious particles. Post-TB airflow obstruction and tobacco-related COPD have the same functional pathway characterized by persistent airflow limitation. We sought to compare the profile of 29 cytokines in the sputum of subjects with post-TB airflow obstruction and those with COPD related to tobacco. RESULTS: The forced expiratory volume in the first second (FEV1) and forced expiratory volume/forced vital capacity (FEV/FVC) ratio were lower in the COPD patients with the history of smoking compared to the post-TB airflow obstruction subgroup. The stages of the disease were more advanced in COPD / tobacco patients. Among the cytokines, IL-1α, IL-1β, MIP-1β, sCD40L and VEGF levels were higher in COPD patients, compared to the controls with p values ​​of 0.003, 0.0001, 0.03, 0.0001 and 0.02 respectively. When the two COPD subgroups were compared, IL-1α, IL-6, TNF-α and IL-8 levels were higher in the COPD patients with the history of tobacco compared to the COPD patients with the history of TB with p-values ​​of 0.031, 0.05, 0.021 and 0.016, respectively. CONCLUSION: COPD related to tobacco is more severe than post-TB airflow obstruction. The pathogenesis of post-TB airflow obstruction appears to involve the cytokines IL-1RA, IL-1α, IL-1β, IL-17, GRO and sCD40L, while COPD related to tobacco involves more cytokines.
format Online
Article
Text
id pubmed-7528576
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75285762020-10-02 Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease Guiedem, Elise Pefura-Yone, Eric Walter Ikomey, George Mondinde Nkenfou, Céline Nguefeu Mesembe, Martha Yivala, Mbanyamsig Mispa Chendi, Bih Hycenta Jacobs, Graeme Brendon Chegou, Novel Njweipi Okomo, Marie Claire Assoumou BMC Immunol Research Article BACKGROUND: Previous studies have shown that tuberculosis (TB) is a risk factor for chronic airflow limitation. Chronic obstructive pulmonary disease (COPD) is recognized as the result of chronic inflammation, usually related to noxious particles. Post-TB airflow obstruction and tobacco-related COPD have the same functional pathway characterized by persistent airflow limitation. We sought to compare the profile of 29 cytokines in the sputum of subjects with post-TB airflow obstruction and those with COPD related to tobacco. RESULTS: The forced expiratory volume in the first second (FEV1) and forced expiratory volume/forced vital capacity (FEV/FVC) ratio were lower in the COPD patients with the history of smoking compared to the post-TB airflow obstruction subgroup. The stages of the disease were more advanced in COPD / tobacco patients. Among the cytokines, IL-1α, IL-1β, MIP-1β, sCD40L and VEGF levels were higher in COPD patients, compared to the controls with p values ​​of 0.003, 0.0001, 0.03, 0.0001 and 0.02 respectively. When the two COPD subgroups were compared, IL-1α, IL-6, TNF-α and IL-8 levels were higher in the COPD patients with the history of tobacco compared to the COPD patients with the history of TB with p-values ​​of 0.031, 0.05, 0.021 and 0.016, respectively. CONCLUSION: COPD related to tobacco is more severe than post-TB airflow obstruction. The pathogenesis of post-TB airflow obstruction appears to involve the cytokines IL-1RA, IL-1α, IL-1β, IL-17, GRO and sCD40L, while COPD related to tobacco involves more cytokines. BioMed Central 2020-10-01 /pmc/articles/PMC7528576/ /pubmed/32998687 http://dx.doi.org/10.1186/s12865-020-00381-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Guiedem, Elise
Pefura-Yone, Eric Walter
Ikomey, George Mondinde
Nkenfou, Céline Nguefeu
Mesembe, Martha
Yivala, Mbanyamsig Mispa
Chendi, Bih Hycenta
Jacobs, Graeme Brendon
Chegou, Novel Njweipi
Okomo, Marie Claire Assoumou
Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
title Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
title_full Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
title_fullStr Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
title_full_unstemmed Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
title_short Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
title_sort cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528576/
https://www.ncbi.nlm.nih.gov/pubmed/32998687
http://dx.doi.org/10.1186/s12865-020-00381-w
work_keys_str_mv AT guiedemelise cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT pefurayoneericwalter cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT ikomeygeorgemondinde cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT nkenfoucelinenguefeu cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT mesembemartha cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT yivalambanyamsigmispa cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT chendibihhycenta cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT jacobsgraemebrendon cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT chegounovelnjweipi cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease
AT okomomarieclaireassoumou cytokineprofileinthesputumofsubjectswithposttuberculosisairflowobstructionandinthosewithtobaccorelatedchronicobstructivepulmonarydisease